health
Investigational ASO improves seizure measures in a DRPLA mouse model
A bioRxiv preprint reports that an antisense oligonucleotide targeting expanded human ATN1 improved seizure-related outcomes in a humanized mouse model of DRPLA. The findings come from mice, not a human treatment study.